| Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues (NCT00539526) | Allergan | 2007-09-01 |
| IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00527501) | Alcon Research | 2007-08-01 |
| Oculusgen (Ologen) Glaucoma MMC Control in Estonia (NCT00524758) | Pro Top & Mediking Company Limited | 2007-07-01 |
| Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery (NCT00538590) | Pro Top & Mediking Company Limited | 2007-07-01 |
| Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) (NCT00545064) | Merck Sharp & Dohme LLC | 2007-05-23 |
| Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells (NCT00478036) | University of Colorado, Denver | 2007-05-01 |
| Progressive Open Angle Glaucoma (OAG) and Ocular Blood Flow (NCT00912470) | Medical University of Vienna | 2007-05-01 |
| A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (NCT00527592) | Alcon Research | 2007-05-01 |
| Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma (NCT00451152) | Alcon Research | 2007-03-01 |
| A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt (NCT00621335) | DBYAN Medicine Professional Corporation | 2007-03-01 |
| Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00465621) | Alcon Research | 2007-03-01 |
| Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension (NCT00471068) | Alcon Research | 2007-03-01 |
| Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma (NCT00443924) | Merck Sharp & Dohme LLC | 2007-03-01 |
| Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines? (NCT00430287) | Wills Eye | 2007-03-01 |
| A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension (NCT00465803) | Alcon Research | 2007-03-01 |
| Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract (NCT00721968) | Glaukos Corporation | 2007-03-01 |
| 24-hour IOP-lowering Effect of Brimonidine 0.1% (NCT00457795) | Allergan | 2006-12-01 |
| Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma. (NCT00440336) | Advanced Glaucoma Specialists | 2006-10-01 |
| Determinants of Compliance With Glaucoma Therapy (NCT01484392) | Legacy Health System | 2006-08-01 |
| A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00326092) | Alcon Research | 2006-05-01 |
| A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00372931) | Alcon Research | 2006-05-01 |
| Anecortave Acetate in Patients With Open-angle Glaucoma (NCT00320203) | Alcon Research | 2006-03-01 |
| Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma (NCT00481208) | Yonsei University | 2006-03-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00293761) | Alcon Research | 2006-01-01 |
| Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients (NCT00665756) | Federal University of São Paulo | 2006-01-01 |
| Lumigan Versus Cosopt (NCT00273455) | Pharmaceutical Research Network | 2006-01-01 |
| A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma (NCT00277498) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-12-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00287521) | Alcon Research | 2005-11-01 |
| A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00314158) | Alcon Research | 2005-11-01 |
| Assessing Cosopt Switch Patients (NCT00273442) | Pharmaceutical Research Network | 2005-11-01 |
| A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00314171) | Alcon Research | 2005-10-01 |
| Determinants of Compliance With Glaucoma Therapy (NCT00362622) | University of Alabama at Birmingham | 2005-10-01 |
| Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation (NCT00918346) | Santen Oy | 2005-09-01 |
| Cosopt Versus Xalacom (NCT00273481) | Pharmaceutical Research Network | 2005-09-01 |
| A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma (NCT00323284) | Glaukos Corporation | 2005-06-01 |
| Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT00822055) | Allergan | 2005-05-01 |
| Latanoprost Versus Fotil (NCT00304785) | Pharmaceutical Research Network | 2005-05-01 |
| Cosopt Versus Xalatan (NCT00273429) | Pharmaceutical Research Network | 2005-04-01 |
| A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients. (NCT00326066) | Glaukos Corporation | 2005-02-01 |
| Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT00822081) | Bp Consulting, Inc | 2005-01-01 |
| Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients (NCT00288951) | Alcon Research | 2004-10-01 |
| Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG) (NCT00716742) | Allergan | 2004-09-01 |
| A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2 (NCT00326079) | Glaukos Corporation | 2004-08-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00293800) | Alcon Research | 2004-07-01 |
| A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution (NCT01485822) | Alcon Research | 2004-07-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00293787) | Alcon Research | 2004-06-01 |
| Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients (NCT00308945) | University Hospital, Basel, Switzerland | 2003-11-01 |
| Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan (NCT00121147) | Hermann Eye Center | 2003-09-01 |
| Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients (NCT00069706) | Alcon Research | 2003-07-01 |
| Study of TRAVATAN in Subjects With Iris Pigmentation Changes (NCT00047554) | Alcon Research | 2003-05-01 |
| A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects (NCT00326040) | Glaukos Corporation | 2003-04-01 |
| A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects. (NCT00326014) | Glaukos Corporation | 2003-04-01 |
| A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00061529) | Alcon Research | 2003-01-01 |
| Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 (NCT00047606) | Alcon Research | 2002-08-01 |
| Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 (NCT00047541) | Alcon Research | 2001-02-01 |
| Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69 (NCT00047515) | Alcon Research | 2001-01-01 |
| Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 (NCT00047528) | Alcon Research | 2001-01-01 |
| Memantine in Patients With Chronic Glaucoma (NCT00168350) | Allergan | 2000-03-01 |
| Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 (NCT00047593) | Alcon Research | 2000-01-01 |
| Memantine in Patients With Chronic Glaucoma (NCT00141882) | Allergan | 1999-03-01 |
| Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients (NCT00069719) | Alcon Research | 1999-02-01 |
| A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients (NCT00856622) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1997-08-01 |
| Collaborative Initial Glaucoma Treatment Study (CIGTS) (NCT00000149) | National Eye Institute (NEI) | 1993-10-01 |
| A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT00751127) | Pfizer | 1993-01-01 |
| A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom (NCT00751049) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1992-12-01 |
| A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia (NCT00751062) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1992-11-01 |
| Early Manifest Glaucoma Trial (EMGT) (NCT00000132) | National Eye Institute (NEI) | 1992-10-01 |
| Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS) (NCT00000144) | National Eye Institute (NEI) | 1984-01-01 |
| Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens (NCT00001161) | National Eye Institute (NEI) | 1977-07-01 |
| Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00657579) | Santen Pharmaceutical Co., Ltd. | |
| Expanded Access to Bimatoprost (Durysta) (NCT05338606) | AbbVie | |
| To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00656240) | Santen Pharmaceutical Co., Ltd. | |